Peregrine Capital Management LLC Myriad Genetics Inc Transaction History
Peregrine Capital Management LLC
- $3.39 Billion
- Q1 2024
A detailed history of Peregrine Capital Management LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Peregrine Capital Management LLC holds 301,257 shares of MYGN stock, worth $7.46 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
301,257
Previous 301,182
0.02%
Holding current value
$7.46 Million
Previous $5.76 Million
11.42%
% of portfolio
0.19%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding MYGN
# of Institutions
191Shares Held
94.2MCall Options Held
280KPut Options Held
14.3K-
Black Rock Inc. New York, NY14.9MShares$368 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$248 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.06MShares$200 Million0.03% of portfolio
-
Camber Capital Management LP Boston, MA7.64MShares$189 Million3.99% of portfolio
-
State Street Corp Boston, MA5.4MShares$134 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...